NCT02584309 : Clinical Trial Detail - Cancer Knowledgebase (CKB)

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT02584309
Title	Doxorubicin With Upfront Dexrazoxane Plus Olaratumab for the Treatment of Advanced or Metastatic Soft Tissue Sarcoma
Recruitment	Completed
Gender	both
Phase	Phase II
Variant Requirements	No
Sponsors	Washington University School of Medicine
Indications	angiosarcoma malignant peripheral nerve sheath tumor malignant fibrous histiocytoma leiomyosarcoma epithelioid sarcoma sarcoma fibrosarcoma synovial sarcoma
Therapies	Dexrazoxane Doxorubicin + Olaratumab
Age Groups:	senior \| adult
Covered Countries	USA

Filter rows:

Showing 1 to 1 of 1 entries

Facility	Status	City	State	Zip	Country	Details
Washington University School of Medicine		Saint Louis	Missouri	63110	United States	Details

Showing 1 to 1 of 1 entries

Filter rows:

*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field

NCT02584309Clinical Trial Detail